These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 10428108)

  • 1. Treatment of mucocutaneous herpes simplex virus infections unresponsive to acyclovir with topical foscarnet cream in AIDS patients: a phase I/II study.
    Javaly K; Wohlfeiler M; Kalayjian R; Klein T; Bryson Y; Grafford K; Martin-Munley S; Hardy WD
    J Acquir Immune Defic Syndr; 1999 Aug; 21(4):301-6. PubMed ID: 10428108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC).
    Snoeck R; Andrei G; Gérard M; Silverman A; Hedderman A; Balzarini J; Sadzot-Delvaux C; Tricot G; Clumeck N; De Clercq E
    Clin Infect Dis; 1994 Apr; 18(4):570-8. PubMed ID: 8038312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pilot study of topical trifluridine for the treatment of acyclovir-resistant mucocutaneous herpes simplex disease in patients with AIDS (ACTG 172). AIDS Clinical Trials Group.
    Kessler HA; Hurwitz S; Farthing C; Benson CA; Feinberg J; Kuritzkes DR; Bailey TC; Safrin S; Steigbigel RT; Cheeseman SH; McKinley GF; Wettlaufer B; Owens S; Nevin T; Korvick JA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jun; 12(2):147-52. PubMed ID: 8680885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of acyclovir-resistant herpetic ulceration with topical foscarnet and antiviral sensitivity analysis.
    Pechère M; Wunderli W; Trellu-Toutous L; Harms M; Saura JH; Krischer J
    Dermatology; 1998; 197(3):278-80. PubMed ID: 9812037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up of HIV-infected patients once diagnosed with acyclovir-resistant herpes simplex virus infection.
    Seang S; Boutolleau D; Burrel S; Regnier S; Epelboin L; Voujon D; Valantin MA; Katlama C; Agut H; Caumes E
    Int J STD AIDS; 2014 Aug; 25(9):676-82. PubMed ID: 24535691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group.
    Safrin S; Crumpacker C; Chatis P; Davis R; Hafner R; Rush J; Kessler HA; Landry B; Mills J
    N Engl J Med; 1991 Aug; 325(8):551-5. PubMed ID: 1649971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of cidofovir in an HIV infected patient with an acyclovir and foscarnet resistant herpes simplex virus infection].
    Saint-Léger E; Fillet AM; Malvy D; Rabanel B; Caumes E
    Ann Dermatol Venereol; 2001; 128(6-7):747-9. PubMed ID: 11460038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind, placebo-controlled trial of cidofovir gel for the treatment of acyclovir-unresponsive mucocutaneous herpes simplex virus infection in patients with AIDS.
    Lalezari J; Schacker T; Feinberg J; Gathe J; Lee S; Cheung T; Kramer F; Kessler H; Corey L; Drew WL; Boggs J; McGuire B; Jaffe HS; Safrin S
    J Infect Dis; 1997 Oct; 176(4):892-8. PubMed ID: 9333146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Foscarnet therapy for severe acyclovir-resistant herpes simplex virus type-2 infections in patients with the acquired immunodeficiency syndrome (AIDS). An uncontrolled trial.
    Erlich KS; Jacobson MA; Koehler JE; Follansbee SE; Drennan DP; Gooze L; Safrin S; Mills J
    Ann Intern Med; 1989 May; 110(9):710-3. PubMed ID: 2522751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical foscarnet for aciclovir-resistant mucocutaneous herpes infections in AIDS.
    Smith NA; Wood C; Asboe D; Bingham JS
    AIDS; 1997 Feb; 11(2):254-5. PubMed ID: 9030377
    [No Abstract]   [Full Text] [Related]  

  • 11. Foscarnet treatment of acyclovir-resistant herpes simplex virus infection in patients with acquired immunodeficiency syndrome: preliminary results of a controlled, randomized, regimen-comparative trial.
    Hardy WD
    Am J Med; 1992 Feb; 92(2A):30S-35S. PubMed ID: 1531285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical Treatment of Acyclovir-Resistant Herpes Simplex Virus Stomatitis after Allogeneic Hematopoietic Cell Transplantation.
    Heidenreich D; Kreil S; Mueller N; Jawhar M; Nolte F; Hofmann WK; Klein SA
    Oncol Res Treat; 2020; 43(12):672-678. PubMed ID: 33070144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Foscarnet therapy for acyclovir-resistant mucocutaneous herpes simplex virus infection in 26 AIDS patients: preliminary data.
    Safrin S; Assaykeen T; Follansbee S; Mills J
    J Infect Dis; 1990 Jun; 161(6):1078-84. PubMed ID: 2161035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acyclovir-resistant, foscarnet-sensitive oral herpes simplex type 2 lesion in a patient with AIDS.
    MacPhail LA; Greenspan D; Schiødt M; Drennan DP; Mills J
    Oral Surg Oral Med Oral Pathol; 1989 Apr; 67(4):427-32. PubMed ID: 2524706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herpes simplex virus type-2 ulcers resistant to acyclovir in an AIDS patient--successful treatment with foscarnet.
    Stellbrink HJ; Albrecht H; Löning T; Greten H
    Klin Wochenschr; 1991 Apr; 69(6):274-8. PubMed ID: 1828096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of acyclovir-resistant herpes simplex virus.
    Chilukuri S; Rosen T
    Dermatol Clin; 2003 Apr; 21(2):311-20. PubMed ID: 12757254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic effects of foscarnet sodium and acyclovir on cutaneous infections due to herpes simplex virus type 1 in guinea pigs.
    Alenius S; Berg M; Broberg F; Eklind K; Lindborg B; Oberg B
    J Infect Dis; 1982 Apr; 145(4):569-73. PubMed ID: 6279738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the DNA polymerase and thymidine kinase genesof herpes simplex virus isolates from AIDS patients in whom acyclovirand foscarnet therapy sequentially failed.
    Schmit I; Boivin G
    J Infect Dis; 1999 Aug; 180(2):487-90. PubMed ID: 10395866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of foscarnet cream, acyclovir cream, and acyclovir ointment in the topical treatment of experimental cutaneous herpes simplex virus type 1 infection.
    Spruance SL; Freeman DJ; Sheth NV
    Antimicrob Agents Chemother; 1986 Jul; 30(1):196-8. PubMed ID: 2944480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of aciclovir and foscarnet resistant Herpes simplex virus lesions with topical imiquimod in patients infected with human immunodeficiency virus type 1.
    Lascaux AS; Caumes E; Deback C; Melica G; Challine D; Agut H; Lévy Y
    J Med Virol; 2012 Feb; 84(2):194-7. PubMed ID: 22170537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.